logo
ZAP Surgical Celebrates 5,000th Patient Treated Globally with ZAP-X

ZAP Surgical Celebrates 5,000th Patient Treated Globally with ZAP-X

Business Wirea day ago
SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced the treatment of the 5,000th patient using its ZAP-X ® Gyroscopic Radiosurgery ® platform — a major milestone reflecting the platform's rapid worldwide adoption.
The case was performed at Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center in Neptune, New Jersey. The patient, Christopher Czerwinski, a 64-year-old Trauma & ICU Nurse, was treated for a right-sided cavernous sinus meningioma. Mr. Czerwinski first noticed diplopia (double vision) nearly two years ago, with symptoms peaking in April 2025 while on vacation at Disney World with his wife — where he humorously recalls seeing two Cinderella castles. An ophthalmologist subsequently referred him for further testing, which led to an MRI and diagnosis. His condition was originally managed with prism glasses and contact lenses.
Mr. Czerwinski ultimately selected Jersey Shore University Medical Center for his radiosurgical care due to the capabilities of the ZAP-X platform and the proven expertise of the medical team. Mr. Czerwinski underwent ZAP-X treatment and tolerated the procedure exceptionally well, resuming his active lifestyle immediately thereafter.
'Stereotactic radiosurgery continues to redefine how we manage challenging cranial conditions,' said Shabbar F. Danish, M.D., FAANS, chair of Neurosurgery, Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center and professor of Neurosurgery, Hackensack Meridian School of Medicine. 'With the precision and versatility of ZAP-X, we were able to deliver focused treatment while minimizing exposure to surrounding critical structures. Mr. Czerwinski's case is a prime example of how we can address complex tumors while preserving quality of life.'
An avid runner and budding pianist, Mr. Czerwinski also enjoys photography, working out with his wife, and spending time with friends and family. As a healthcare provider himself, he expressed deep appreciation for the compassionate care he received and the non-invasive nature of the ZAP-X procedure.
'I'm pleased our clinical experts have enabled the communities we serve to receive this advanced procedure at our academic medical center, without the need to travel far from home,' said Vito Buccellato, MPA, LNHA, president and chief hospital executive of Jersey Shore University Medical Center.
The ZAP-X platform represents a new frontier in cranial radiosurgery. By employing gyroscopic beam delivery, ZAP-X can direct radiation from thousands of angles to concentrate dose on the tumor while sparing healthy brain tissue and helping protect nearby organs at risk, such as the optic nerves and brainstem. The procedure is painless, incisionless, and often completed in a single outpatient session — without the need for anesthesia or hospital admission.
'The treatment of our 5,000th patient not only represents a numerical milestone, but a reaffirmation of our mission to make brain radiosurgery safer, smarter, and more accessible,' said John R. Adler, M.D., founder and CEO of ZAP Surgical, and Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University.
ZAP-X is the first and only dedicated cranial SRS platform that does not require radioactive Cobalt-60. Instead, it uses a modern linear accelerator to generate radiation, eliminating the safety, storage, and regulatory challenges associated with isotope-based systems. Furthermore, ZAP-X is the only vault-free solution in its category, thereby allowing installation in clinical settings with interior and exterior facing windows.
'We recruited experts in their fields, Dr. Shabbar Danish and Dr. Timothy Chen, in part so that we could add to the available, leading-edge treatment technologies at Jersey Shore and HMH,' said Kenneth N. Sable, M.D., MBA, FACEP, president, Acute Hospital Division, Hackensack Meridian Health. 'I'm thrilled that the 5,000th patient to receive ZAP-X treatment is from our local community.'
For information about Jersey Shore University Medical Center's ZAP-X program, visit www.hackensackmeridianhealth.org/en/services/neurosciences/gyroscopic-radiosurgery-integrated-with-magnetic-resonance-imaging.
About ZAP Surgical Systems, Inc.
ZAP Surgical Systems, Inc. designs and manufactures the ZAP-X ® Gyroscopic Radiosurgery ® platform. ZAP was founded in 2014 by Dr. John R. Adler, Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. Dr. Adler is also renowned as the inventor of the CyberKnife ® system and founder of Accuray, Inc. The ZAP-X platform incorporates a unique vault-free design that typically eliminates the need for costly shielded treatment rooms. ZAP-X also utilizes a modern linear accelerator to eliminate legacy use of Cobalt-60. Learn more at www.zapsurgical.com and follow us on LinkedIn.
Hackensack Meridian Health is a leading not-for-profit health care organization and New Jersey's largest, most comprehensive, and integrated health network. Our network includes 18 hospitals, more than 500 patient care locations, and a complete range of services from innovative research and life-enhancing care to lifesaving air medical transportation. Our 38,000 team members and 7,000 physicians are committed to the health and well-being of the communities we serve, making Hackensack Meridian Health a distinguished leader in healthcare philanthropy.
Hackensack University Medical Center is the first-ever New Jersey hospital to be ranked a Top 20 hospital in the nation. It is also ranked #1 in New Jersey and the New York metro area by U.S. News & World Report, 2025-26. Hackensack Meridian Health is proud to be home to New Jersey's #1 children's hospital and the state's only nationally-ranked cancer center, the John Theurer Cancer Center. To learn more, visit www.hackensackmeridianhealth.org.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ZAP Surgical Celebrates 5,000th Patient Treated Globally with ZAP-X
ZAP Surgical Celebrates 5,000th Patient Treated Globally with ZAP-X

Business Wire

timea day ago

  • Business Wire

ZAP Surgical Celebrates 5,000th Patient Treated Globally with ZAP-X

SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced the treatment of the 5,000th patient using its ZAP-X ® Gyroscopic Radiosurgery ® platform — a major milestone reflecting the platform's rapid worldwide adoption. The case was performed at Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center in Neptune, New Jersey. The patient, Christopher Czerwinski, a 64-year-old Trauma & ICU Nurse, was treated for a right-sided cavernous sinus meningioma. Mr. Czerwinski first noticed diplopia (double vision) nearly two years ago, with symptoms peaking in April 2025 while on vacation at Disney World with his wife — where he humorously recalls seeing two Cinderella castles. An ophthalmologist subsequently referred him for further testing, which led to an MRI and diagnosis. His condition was originally managed with prism glasses and contact lenses. Mr. Czerwinski ultimately selected Jersey Shore University Medical Center for his radiosurgical care due to the capabilities of the ZAP-X platform and the proven expertise of the medical team. Mr. Czerwinski underwent ZAP-X treatment and tolerated the procedure exceptionally well, resuming his active lifestyle immediately thereafter. 'Stereotactic radiosurgery continues to redefine how we manage challenging cranial conditions,' said Shabbar F. Danish, M.D., FAANS, chair of Neurosurgery, Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center and professor of Neurosurgery, Hackensack Meridian School of Medicine. 'With the precision and versatility of ZAP-X, we were able to deliver focused treatment while minimizing exposure to surrounding critical structures. Mr. Czerwinski's case is a prime example of how we can address complex tumors while preserving quality of life.' An avid runner and budding pianist, Mr. Czerwinski also enjoys photography, working out with his wife, and spending time with friends and family. As a healthcare provider himself, he expressed deep appreciation for the compassionate care he received and the non-invasive nature of the ZAP-X procedure. 'I'm pleased our clinical experts have enabled the communities we serve to receive this advanced procedure at our academic medical center, without the need to travel far from home,' said Vito Buccellato, MPA, LNHA, president and chief hospital executive of Jersey Shore University Medical Center. The ZAP-X platform represents a new frontier in cranial radiosurgery. By employing gyroscopic beam delivery, ZAP-X can direct radiation from thousands of angles to concentrate dose on the tumor while sparing healthy brain tissue and helping protect nearby organs at risk, such as the optic nerves and brainstem. The procedure is painless, incisionless, and often completed in a single outpatient session — without the need for anesthesia or hospital admission. 'The treatment of our 5,000th patient not only represents a numerical milestone, but a reaffirmation of our mission to make brain radiosurgery safer, smarter, and more accessible,' said John R. Adler, M.D., founder and CEO of ZAP Surgical, and Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. ZAP-X is the first and only dedicated cranial SRS platform that does not require radioactive Cobalt-60. Instead, it uses a modern linear accelerator to generate radiation, eliminating the safety, storage, and regulatory challenges associated with isotope-based systems. Furthermore, ZAP-X is the only vault-free solution in its category, thereby allowing installation in clinical settings with interior and exterior facing windows. 'We recruited experts in their fields, Dr. Shabbar Danish and Dr. Timothy Chen, in part so that we could add to the available, leading-edge treatment technologies at Jersey Shore and HMH,' said Kenneth N. Sable, M.D., MBA, FACEP, president, Acute Hospital Division, Hackensack Meridian Health. 'I'm thrilled that the 5,000th patient to receive ZAP-X treatment is from our local community.' For information about Jersey Shore University Medical Center's ZAP-X program, visit About ZAP Surgical Systems, Inc. ZAP Surgical Systems, Inc. designs and manufactures the ZAP-X ® Gyroscopic Radiosurgery ® platform. ZAP was founded in 2014 by Dr. John R. Adler, Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. Dr. Adler is also renowned as the inventor of the CyberKnife ® system and founder of Accuray, Inc. The ZAP-X platform incorporates a unique vault-free design that typically eliminates the need for costly shielded treatment rooms. ZAP-X also utilizes a modern linear accelerator to eliminate legacy use of Cobalt-60. Learn more at and follow us on LinkedIn. Hackensack Meridian Health is a leading not-for-profit health care organization and New Jersey's largest, most comprehensive, and integrated health network. Our network includes 18 hospitals, more than 500 patient care locations, and a complete range of services from innovative research and life-enhancing care to lifesaving air medical transportation. Our 38,000 team members and 7,000 physicians are committed to the health and well-being of the communities we serve, making Hackensack Meridian Health a distinguished leader in healthcare philanthropy. Hackensack University Medical Center is the first-ever New Jersey hospital to be ranked a Top 20 hospital in the nation. It is also ranked #1 in New Jersey and the New York metro area by U.S. News & World Report, 2025-26. Hackensack Meridian Health is proud to be home to New Jersey's #1 children's hospital and the state's only nationally-ranked cancer center, the John Theurer Cancer Center. To learn more, visit

FX's 'Alien: Earth' is everything 'Alien' fans could want: Review
FX's 'Alien: Earth' is everything 'Alien' fans could want: Review

USA Today

timea day ago

  • USA Today

FX's 'Alien: Earth' is everything 'Alien' fans could want: Review

There's nothing quite like the primal fear that the "Alien" franchise can instill in viewers. The original 1979 Ridley Scott film is a classic for a reason, a master class in body horror and bone-jangling terror grounded in philosophical musings and deeply uncomfortable truths about humanity. The face-hugging xenomorph aliens of the film aren't just scary, they're violating in their torrent of consumption and obliteration, their cold, ceaseless hunger the very anathema of the warmth and hope of the human condition. Noah Hawley, creator of FX's "Fargo" and trippy X-Men series "Legion," fundamentally understands what makes the aliens of "Alien" scary, and what makes the world Scott created so enticing to return to for film after film. His big-budget, big-impact FX series "Alien: Earth" (Tuesdays, 8 ET/PT, streaming simultaneously on Hulu, ★★★½ out of four), the first time "Alien" has graced the small screen, is a worthy entry in the franchise. Literally bringing things down to Earth, the series manages to preserve the aesthetics and feeling of "Alien" while creating a truly unique, compelling story. By the time you finish eight episodes of terror, both comfortingly familiar and disturbingly novel, you might feel the same way you did after watching the film. "Earth" smacks you in the face with all things "Alien" from its very first moments, describing a capitalist world controlled by corporations instead of governments, and bringing us to a deep space research vessel with sleep pods and a congenial crew. Nothing could possibly go wrong with all the vicious alien specimens on board, right? Well, as this doomed spacecraft comes crashing down to Earth, it encounters a world where those powerful corporations are vying for a scientific answer to mortality itself. There are "cyborgs," humans who have been altered with technology; "synths," full-on robots like the android Ash (played by Ian Holm in the original film); and a new category of being: "hybrids," human minds who have been downloaded into a synthetic body. Annoying trillionaire Boy Kavalier (Samuel Blenkin) is experimenting with hybrids, by downloading children's brains into adult bodies. The very first hybrid is Wendy (Sydney Chandler), self-named after the "Peter Pan" character (there is heavy-handed homage to the J.M. Barrie story throughout). She has what appear to be limitless physical and cybernetic powers that are only getting stronger. When Wendy discovers her brother Hermit (Alex Lawther) is a first responder investigating the crash of that contaminated spacecraft, she manages to get herself and her fellow synths deployed in search and rescue. The series sets the various human and humanoid segments of its cast on a direct course with the distinctly inhuman alien flora and fauna on the ship – there are some inventive little monsters aboard, disgusting and harrowing in their own special ways – to great effect. Everyone wants what's on the spacecraft, for profit or discovery or just to kill to protect others. The aliens simply want to divide, devour and destroy. Hawley's scripts and deft direction create a near-constant tension and apprehension in each episode, jam-packed with action and violence. Its opening installments even find a way to cram in some exposition amid all the terror and mayhem, but by the end of the season the ceaseless adrenaline and motion of the plot is something to behold. But lest you think all that action leaves little time for something more intellectual, "Earth" is deeply philosophical, sometimes so overtly so it's a bit too on the nose. When Timothy Olyphant's dead-eyed "synth," informs Wendy that humans are all really just food, it's hard not to feel as though we're being beaten over the head with the show's theme. But anyone who has seen Hawley's "Legion" will easily spot his penchant for asking questions about what makes us human and why. And fans of his five seasons of "Fargo" adaptations will see his penchant for sprawling casts full of idiosyncratic characters that are lovable in odd and surprising ways. The actors portraying the child/adult hybrids never lose the physicality of adolescence, even as they tumble about at full height. Olyphant and the other humanoid characters radiate a robotic alienness all their own. The series is immersive even before any extraterrestrials try to hug your face. "Earth" has many masters to serve: The "Alien" fans who want a faithful extension of their beloved franchise, Disney and FX, seeking a hit that will bring in the film's fans and newcomers alike, plus all those fans watching. It must do all this and make a coherent story in the process. The series pleases all, without ever giving into something gimmicky or tawdry with the signature long-headed monster at its core. You'll certianly hear yourself scream at the horrors the show creates.

ZAP Surgical Celebrates 5,000th Patient Treated Globally with ZAP-X® Gyroscopic Radiosurgery® Platform
ZAP Surgical Celebrates 5,000th Patient Treated Globally with ZAP-X® Gyroscopic Radiosurgery® Platform

Business Wire

timea day ago

  • Business Wire

ZAP Surgical Celebrates 5,000th Patient Treated Globally with ZAP-X® Gyroscopic Radiosurgery® Platform

SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced the treatment of the 5,000th patient using its ZAP-X® Gyroscopic Radiosurgery® platform — a major milestone reflecting the platform's rapid worldwide adoption. The case was performed at Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center in Neptune, New Jersey. The patient, Christopher Czerwinski, a 64-year-old Trauma & ICU Nurse, was treated for a right-sided cavernous sinus meningioma. Mr. Czerwinski first noticed diplopia (double vision) nearly two years ago, with symptoms peaking in April 2025 while on vacation at Disney World with his wife — where he humorously recalls seeing two Cinderella castles. An ophthalmologist subsequently referred him for further testing, which led to an MRI and diagnosis. His condition was originally managed with prism glasses and contact lenses. Mr. Czerwinski ultimately selected Jersey Shore University Medical Center for his radiosurgical care due to the capabilities of the ZAP-X platform and the proven expertise of the medical team. Mr. Czerwinski underwent ZAP-X treatment and tolerated the procedure exceptionally well, resuming his active lifestyle immediately thereafter. 'Stereotactic radiosurgery continues to redefine how we manage challenging cranial conditions,' said Shabbar F. Danish, M.D., FAANS, chair of Neurosurgery, Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center and professor of Neurosurgery, Hackensack Meridian School of Medicine. 'With the precision and versatility of ZAP-X, we were able to deliver focused treatment while minimizing exposure to surrounding critical structures. Mr. Czerwinski's case is a prime example of how we can address complex tumors while preserving quality of life.' An avid runner and budding pianist, Mr. Czerwinski also enjoys photography, working out with his wife, and spending time with friends and family. As a healthcare provider himself, he expressed deep appreciation for the compassionate care he received and the non-invasive nature of the ZAP-X procedure. 'I'm pleased our clinical experts have enabled the communities we serve to receive this advanced procedure at our academic medical center, without the need to travel far from home,' said Vito Buccellato, MPA, LNHA, president and chief hospital executive of Jersey Shore University Medical Center. The ZAP-X platform represents a new frontier in cranial radiosurgery. By employing gyroscopic beam delivery, ZAP-X can direct radiation from thousands of angles to concentrate dose on the tumor while sparing healthy brain tissue and helping protect nearby organs at risk, such as the optic nerves and brainstem. The procedure is painless, incisionless, and often completed in a single outpatient session — without the need for anesthesia or hospital admission. 'The treatment of our 5,000th patient not only represents a numerical milestone, but a reaffirmation of our mission to make brain radiosurgery safer, smarter, and more accessible,' said John R. Adler, M.D., founder and CEO of ZAP Surgical, and Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. ZAP-X is the first and only dedicated cranial SRS platform that does not require radioactive Cobalt-60. Instead, it uses a modern linear accelerator to generate radiation, eliminating the safety, storage, and regulatory challenges associated with isotope-based systems. Furthermore, ZAP-X is the only vault-free solution in its category, thereby allowing installation in clinical settings with interior and exterior facing windows. 'We recruited experts in their fields, Dr. Shabbar Danish and Dr. Timothy Chen, in part so that we could add to the available, leading-edge treatment technologies at Jersey Shore and HMH,' said Kenneth N. Sable, M.D., MBA, FACEP, president, Acute Hospital Division, Hackensack Meridian Health. 'I'm thrilled that the 5,000th patient to receive ZAP-X treatment is from our local community.' For information about Jersey Shore University Medical Center's ZAP-X program, visit About ZAP Surgical Systems, Inc. ZAP Surgical Systems, Inc. designs and manufactures the ZAP-X® Gyroscopic Radiosurgery® platform. ZAP was founded in 2014 by Dr. John R. Adler, Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. Dr. Adler is also renowned as the inventor of the CyberKnife® system and founder of Accuray, Inc. The ZAP-X platform incorporates a unique vault-free design that typically eliminates the need for costly shielded treatment rooms. ZAP-X also utilizes a modern linear accelerator to eliminate legacy use of Cobalt-60. Learn more at and follow us on LinkedIn. ABOUT HACKENSACK MERIDIAN HEALTH Hackensack Meridian Health is a leading not-for-profit health care organization and New Jersey's largest, most comprehensive, and integrated health network. Our network includes 18 hospitals, more than 500 patient care locations, and a complete range of services from innovative research and life-enhancing care to lifesaving air medical transportation. Our 38,000 team members and 7,000 physicians are committed to the health and well-being of the communities we serve, making Hackensack Meridian Health a distinguished leader in healthcare philanthropy. Hackensack University Medical Center is the first-ever New Jersey hospital to be ranked a Top 20 hospital in the nation. It is also ranked #1 in New Jersey and the New York metro area by U.S. News & World Report, 2025-26. Hackensack Meridian Health is proud to be home to New Jersey's #1 children's hospital and the state's only nationally-ranked cancer center, the John Theurer Cancer Center. To learn more, visit

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store